Citi Field Curse: Jeurys Familia Diagnosed with Blood Clot

0
NEW YORK, NEW YORK - MAY 10: Jeurys Familia #27 of the New York Mets walks off the mound in the ninth inning after giving up four runs against the San Francisco Giants at Citi Field on May 10, 2017 in the Flushing neighborhood of the Queens borough of New York City. (Photo by Mike Stobe/Getty Images)

The Citi Field Curse of 2017

The Citi Field Curse of 2017 rears its ugly head once again, this time striking New York Mets closer Jeurys Familia. Early reports state that team doctors diagnosed Familia with a blood clot in his right arm. The injury comes less than a month after Familia rejoined the team following a 15-game ban. The suspension came from a violation of the league’s domestic violence policy.

Familia owns a 3.86 ERA over 9.1 innings pitched this season, appearing in 11 games. The 2016 All-Star, who tallied 51 saves last year, showed signs of rust this season. He has struggled late in games, and reports state that he was uninterested in last night’s match. It’s tough to say when he might return to the active roster. As reported by Joel Sherman, of the New York Post:

Mets options are limited

David Cone suffered a similar setback in 1996, and missed four months. Depending on the treatment plan devised by Dr. Thompson, Familia’s 2017 season may be a wash. As the Mets injury woes continue, it is becoming obvious that there is something wrong with either the front office, the coaching staff, or the clubhouse culture. The buck stops at the General Manager, Sandy Alderson, who needs to look at the health and wellness policies for the team.

Travis d’Arnaud, Noah Syndergaard, Yoenis Cespedes, Lucas Duda, Seth Lugo, Steven Matz, Brandon Nimmo, and David Wright have all fallen to injury prior to this news. The injury to Familia costs the Mets one more valuable arm. The Mets are in a free fall, and there are few assets to sell for future building. Terry Collins has major work to do and little in the way of time or materials to do it with.

Main Photo:

LEAVE A REPLY